pubmed.ncbi.nlm.nih.gov

PD123319 augments angiotensin II-induced abdominal aortic aneurysms through an AT2 receptor-independent mechanism - PubMed

  • ️Tue Jan 01 2013

PD123319 augments angiotensin II-induced abdominal aortic aneurysms through an AT2 receptor-independent mechanism

Alan Daugherty et al. PLoS One. 2013.

Abstract

Background: AT2 receptors have an unclear function on development of abdominal aortic aneurysms (AAAs), although a pharmacological approach using the AT2 receptor antagonist PD123319 has implicated a role. The purpose of the present study was to determine the role of AT2 receptors in AngII-induced AAAs using a combination of genetic and pharmacological approaches. We also defined effects of AT2 receptors in AngII-induced atherosclerosis and thoracic aortic aneurysms.

Methods and results: Male AT2 receptor wild type (AT2 +/y) and deficient (AT2 -/y) mice in an LDL receptor -/- background were fed a saturated-fat enriched diet, and infused with either saline or AngII (500 ng/kg/min). AT2 receptor deficiency had no significant effect on systolic blood pressure during AngII-infusion. While AngII infusion induced AAAs, AT2 receptor deficiency did not significantly affect either maximal width of the suprarenal aorta or incidence of AAAs. The AT2 receptor antagonist PD123319 (3 mg/kg/day) and AngII were co-infused into male LDL receptor -/- mice that were either AT2 +/y or -/y. PD123319 had no significant effect on systolic blood pressure in either wild type or AT2 receptor deficient mice. Consistent with our previous findings, PD123319 increased AngII-induced AAAs. However, this effect of PD123319 occurred irrespective of AT2 receptor genotype. Neither AT2 receptor deficiency nor PD123319 had any significant effect on AngII-induced thoracic aortic aneurysms or atherosclerosis.

Conclusions: AT2 receptor deficiency does not affect AngII-induced AAAs, thoracic aortic aneurysms and atherosclerosis. PD123319 augments AngII-induced AAAs through an AT2 receptor-independent mechanism.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. AT2 receptor deficiency did not change suprarenal aortic expansion in mice infused with AngII.

Maximal aortic width of suprarenal aortas was measured ex vivo. Circles and inverted triangles represent values from individual mice, diamonds are mean values of each group, and bars are SEM. * P = 0.002 between AngII-infused groups and saline-infused groups as analyzed by two way ANOVA. There were no significant effects of genotype (AT2 +/y versus AT2 −/y) on aortic width.

Figure 2
Figure 2. AT2 receptor deficiency did not change expansion of the aortic arch region in mice infused with AngII.

Intimal area of aortic arches was calculated from en face measurements. Circles and inverted triangles represent values from individual mice, diamonds are mean values of each group, and bars are SEM. * P = 0.0003 between AngII-infused and saline-infused groups as analyzed by two way ANOVA. There were no significant effects of genotype (AT2 +/y versus AT2 −/y) on intimal areas of aortic arches.

Figure 3
Figure 3. AT2 receptor deficiency did not change percent atherosclerotic lesion area in mice infused with AngII.

Percent atherosclerotic lesion area of aortic arches was calculated as lesion area/intimal surface area (x 100%). Circles and inverted triangles represent values from individual mice, diamonds are mean values of each group, and bars are SEM. * P<0.0001 between AngII-infused groups and saline-infused groups as analyzed by two way ANOVA. There were no significant effects of genotype (AT2 +/y versus AT2 −/y) on lesion areas.

Figure 4
Figure 4. PD123319 augmented AngII-induced suprarenal aortic expansion and incidence of AAAs independent of AT2 receptor genotype.

A. Maximal aortic width of suprarenal aortas was measured ex vivo. Circles and inverted triangles represent values from individual mice, diamonds are mean values of each group, and bars are SEM. * P = 0.01 between AngII-infused and PD123319-infused groups as analyzed by two way ANOVA. There were no significant effects on aortic width for genotypes (AT2 +/y versus AT2 −/y). B. Incidence of AAAs. * P = 0.006 between AngII-infused and PD123319-infused groups as analyzed by Fisher's Exact test. There were no significant effects of genotype (AT2 +/y versus AT2 −/y) on incidence of AAAs.

Figure 5
Figure 5. PD123319 did not change AngII-induced expansion of the aortic arch region.

Intimal area of aortic arches was measured using an en face method after termination. Circles and inverted triangles represent values from individual mice, diamonds are mean values of each group, and bars are SEM. There were no significant effects of genotype (AT2 +/y versus AT2 -/y) or PD123319 on intimal areas of the aortic arch region, as demonstrated by two way ANOVA.

Figure 6
Figure 6. PD123319 did not change atherosclerotic lesion size in mice infused with AngII.

Percent atherosclerotic lesion area of aortic arches was calculated as lesion area/intimal surface area (x 100%). Circles and inverted triangles represent values from individual mice, diamonds are mean values of each group, and bars are SEM. There were no significant effects of genotype (AT2 +/y versus AT2 −/y) or PD123319 on lesion areas, as demonstrated by two way ANOVA.

Similar articles

Cited by

References

    1. Daugherty A, Manning MW, Cassis LA (2000) Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105: 1605–1612. - PMC - PubMed
    1. Daugherty A, Cassis L (1999) Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor −/− mice. Ann NY Acad Sci 892: 108–118. - PubMed
    1. Daugherty A, Rateri DL, Charo IF, Owens AP, Howatt DA, et al. (2010) Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE−/− mice. Clin Sci (Lond) 118: 681–689. - PMC - PubMed
    1. Rateri DL, Moorleghen JJ, Balakrishnan A, Owens AP 3rd, Howatt DA et al (2011) Endothelial cell-specific deficiency of Ang II type 1a receptors attenuates Ang II-induced ascending aortic aneurysms in LDL receptor−/− mice. Circ Res 108: 574–581. - PMC - PubMed
    1. Carey RM, Wang ZQ, Siragy HM (2000) Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function. Hypertension 35: 155–163. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources